Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma.

Alfredo Adolfo Reza-Albarrán Gerson Geovany Andino-RíosLaura Gabriela Gómez Herrera

Published in: Clinical case reports (2018)

Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.

Keyphrases

case report
early onset
emergency department
respiratory tract